Lynne Cesario

Senior Director, Risk Based Monitoring Program Lead, Pfizer

Lynne's Session

[September 9, 2022]
11:30 AM EST
Theme: Panel: The New Risk-Based Norm – What Transformative Outcomes (From the Last Two Years) Are Here to Stay?